Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia-Reference-Cited by-同舟云学术

Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia

Published:2015-07 Issue:7 Volume:12 Page:1636-1643
ISSN:1547-5271
Container-title:Heart Rhythm
language:en
Short-container-title:Heart Rhythm

Author:

Wangüemert Fernando,Bosch Calero Cristina,Pérez Carmelo,Campuzano Oscar,Beltran-Alvarez Pedro,Scornik Fabiana S.,Iglesias Anna,Berne Paola,Allegue Catarina,Ruiz Hernandez Pablo M.,Brugada Josep,Pérez Guillermo J.,Brugada Ramon

Publisher

Elsevier BV

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients;Leenhardt;Circulation,1995

2. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia;Hayashi;Circulation,2009

3. Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives;Van der Werf;Circ Arrhythm Electrophysiol,2012

4. Catecholaminergic-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases;Coumel;Br Hear J,1978

5. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients;Postma;J Med Genet,2005

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arrhythmogenic foods—An underestimated medical problem?;Heart Rhythm;2024-07

2. Prognosis and clinical management of asymptomatic family members with RYR2-mediated catecholaminergic polymorphic ventricular tachycardia: a review;Cardiology in the Young;2024-04-24

3. Current gaps in knowledge in inherited arrhythmia syndromes;Netherlands Heart Journal;2023-07-06

4. Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia;Heart, Lung and Circulation;2023-07

5. RYR2-ryanodinopathies: from calcium overload to calcium deficiency;Europace;2023-06